BACKGROUND: The association between plasma @entity1254 and @entity209 may be impaired in heart transplant recipients, since @entity177 is frequent among these @entity1 . Thus, we studied the relationship between @entity209 and plasma @entity1254 in transplanted heart recipients. METHODS: Ninety-five heart transplant recipients were prospectively included 8.3 +/- 5.6 yr after transplantation in this cross-sectional study. All @entity1 had physical examination, echocardiography or routine biennial coronary angiography, and laboratory measurements. RESULTS: @entity209 was found in 31% of these @entity1 . Plasma @entity1254 was significantly lower in @entity1 with @entity209 (12.5 +/- 8.3 microg/mL) than in @entity1 without (16.7 +/- 9.4 microg/mL, p = 0.03). @entity1254 levels were usually in the normal or high range (< 4 microg/mL in only two @entity1 ). Low @entity1011 clearance was associated with higher plasma @entity1254 (R=-0.26, p = 0.01). Plasma @entity1254 was not significantly different between the 28 @entity1 with angiographic evidence of graft vasculopathy (13.9 +/- 9.5 microg/mL) and the 67 @entity1 without (16.1 +/- 9.1 microg/mL, p = 0.3). CONCLUSIONS: Contrasting with a high frequency of @entity209 in these @entity1 , @entity1254 levels were usually in the normal or high range, probably as a consequence of @entity177 . This suggests that @entity1254 is not a major determinant for insulin resistance among these @entity1 .

Plasma XXXX in heart transplant recipients.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity177 :: ('MESH:D051437', 'Disease') :: ['renal failure'] @entity1254 :: ('9370', 'Gene') :: ['Adiponectin', 'adiponectin'] @entity1011 :: ('MESH:D003404', 'Chemical') :: ['creatinine'] @entity209 :: ('MESH:D008659', 'Disease') :: ['Metabolic syndrome', 'metabolic syndrome']
@entity1254 :: (9370,Gene) :: ['adiponectin']
